scholarly journals P2-446: VALIDATION OF ANXIETY SENSITIVITY INDEX (ASI-16) ON NONCLINICAL SAMPLE OF RWANDANS: A CROSS-SECTIONAL STUDY

2019 ◽  
Vol 15 ◽  
pp. P785-P785
Author(s):  
Emmanuel Biracyaza
2018 ◽  
Vol 7 (1) ◽  
pp. 53
Author(s):  
Emmanuel Biracyaza ◽  
Jean Mutabaruka ◽  
Samuel Habimana

Globally, anxiety diseases are the mental health concerns that increase the mortality and morbidity. Anxiety sensitivity (AS) refers to the tendency of individuals to fear anxiety-related symptoms due to the belief that these symptoms may have destructive consequences. A cross-sectional study was conducted to validate ASI-16 on a non-psychiatric sample of 90 recruited students from the University of Rwanda. The recruited participants were aged 19 to 37 years old [(Mean age (M=23.9, SD = 3.69)]. The findings confirmed a good internal consistence (Cronbach’s Alpha, α= 0.83). The results revealed the ASI-16 criterion related convergent validity of ASI-16 (r=.59; p=.000; ASI and STAI) and criterion related concurrent validity (r=.069; p=.51; ASI and BDI). Using factor analysis, the findings showed an overlapping of physical, psychological and social aspects attesting that ASI is one-dimensional tool assessing anxiety symptoms. More than a quarter (1/4) of items seemed to assess all three factors of ASI; this attested that there were interconnections between physical, psychological or cognitive and social aspects. The participants who scored highly were considered to have the anxiety symptoms. In the present sample, the t-test was computed to compare males and females on the ASI-16 total scores and showed that there was no significant difference at 5% level [(Mean of males=29.3, Mean of females=29.57), t (26.176) at p=.000]. The results confirmed that ASI-16 seems to be valid and reliable to screen anxiety symptoms in a Rwandan sample. ASI’s norms should be constructed on the Rwandan population.


2021 ◽  
Author(s):  
GÖKÇE İŞCAN ◽  
BÜLENT ÇETİN ◽  
FARUK KILIÇ ◽  
HAKAN KALAYCI ◽  
AYŞEGÜL KALAYCI

Abstract Introduction: The goal of our research was to look into the perspectives of cancer patients who had not yet been vaccinated, aged from 21 to 88 years old and had applied to Süleyman Demirel University's oncology outpatient clinic in May and June, as well as their anxieties and concerns about vaccination. Methods The goal of this descriptive cross-sectional study was to investigate cancer patients’ perceptions of Covid vaccination. We applied 3 questionnaires, one of them prepared by us, the other two questionnaires were The State-Trait Anxiety Inventory (STAI) form and Anxiety Sensitivity index to a total of 497 participants. Chi-Square, Spearmen correlation test, multivariable multinomial logistic regression tests were used when comparing. Results Our participants were between the ages of 21 and 88, with a mean age of 61,38 (SD = 11,68). 48,6% (n=251) of all participants were female. We discovered that 79.1% (n=408) of respondents were not afraid of getting the COVID-19 vaccine. 27,7 % (n=143) of this population's respondents were concerned about the COVID-19 vaccine's negative effects and 24,2% (n=125) were afraid of its side effects with their treatments. 91,1% (n=470) of the patients did not know which vaccine they would have and the type of the vaccine. Due to the high level of anxiety in women in general, it was thought that anxiety scores were higher in patients with breast and ovarian cancer, which are important cancers in women during the pandemic period, while anxiety scores were lower in patients with prostate cancer since it was seen in men. Special patient groups should not be neglected during this vaccine season, and their concerns should be addressed. When a new vaccine is found, it can have long-term effects, which should not be ignored.


2013 ◽  
Vol 93 (12) ◽  
pp. 1615-1624 ◽  
Author(s):  
Andrew J. Baird ◽  
Roger A. Haslam

Background Beliefs, cognitions, and behaviors relating to pain can be associated with a range of negative outcomes. In patients, certain beliefs are associated with increased levels of pain and related disability. There are few data, however, showing the extent to which beliefs of patients differ from those of the general population. Objective This study explored pain beliefs in a large nonclinical population and a chronic low back pain (CLBP) sample using the Pain Beliefs Questionnaire (PBQ) to identify differences in scores and factor structures between and within the samples. Design This was a cross-sectional study. Methods The samples comprised patients attending a rehabilitation program and respondents to a workplace survey. Pain beliefs were assessed using the PBQ, which incorporates 2 scales: organic and psychological. Exploratory factor analysis was used to explore variations in factor structure within and between samples. The relationship between the 2 scales also was examined. Results Patients reported higher organic scores and lower psychological scores than the nonclinical sample. Within the nonclinical sample, those who reported frequent pain scored higher on the organic scale than those who did not. Factor analysis showed variations in relation to the presence of pain. The relationship between scales was stronger in those not reporting frequent pain. Limitations This was a cross-sectional study; therefore, no causal inferences can be made. Conclusions Patients experiencing CLBP adopt a more biomedical perspective on pain than nonpatients. The presence of pain is also associated with increased biomedical thinking in a nonclinical sample. However, the impact is not only on the strength of beliefs, but also on the relationship between elements of belief and the underlying belief structure.


2010 ◽  
Vol 106 (2) ◽  
pp. 448-454 ◽  
Author(s):  
Karin Österman ◽  
Kaj Björkqvist

Temper tantrums among young children were investigated with the questionnaire Parents' Experiences of Temper Tantrums in Children. Parents of 132 children (101 mothers, 31 fathers) in a largely Swedish-speaking area of Finland completed the questionnaire. 87% of the parents reported that one or more of their children had had temper tantrums. Of all children in the study, 64.7% began having tantrums when they were 2 or 3 years old; 57.1% did not have tantrums anymore after age five. For 46.5% of the cases, the tantrums lasted between 5 and 10 minutes. There was no sex difference for age of onset of tantrums, age when tantrums ceased, age span during which they occurred, frequency, or duration of episodes.


2011 ◽  
Vol 106 (8) ◽  
pp. 1245-1252 ◽  
Author(s):  
Birgit M. Nielsen ◽  
Marie M. Nielsen ◽  
Marianne U. Jakobsen ◽  
Carina J. Nielsen ◽  
Claus Holst ◽  
...  

Intake oftrans-fatty acids (TFA), especially industrially produced TFA (I-TFA), has been associated with the risk of CHD through influence on serum lipid levels. Other causal pathways remain less investigated. In the present cross-sectional study of middle-aged men representing a broad range of BMI, the association between intake of TFA, I-TFA and ruminant TFA (R-TFA) and obesity-associated risk markers of CHD was assessed. The study comprised 393 Danish men (median age 49 years) with a median BMI of 28·4 kg/m2. Intake of TFA was estimated based on 7 d dietary records, whereas outcomes of interest (waist circumference, sagittal abdominal diameter, percentage of truncal fat, C-reactive protein, IL-6, blood lipids, blood pressure, HbA1c and insulin sensitivity index) were obtained through clinical examination. The associations were assessed by linear regression analysis. The median intake of total TFA among the 393 men was 1·3 g/d, covering a daily I-TFA intake of 0·4 g (10–90th percentile 0·0–1·0) and R-TFA intake of 0·9 g (10–90th percentile 0·4–1·8). Intake of these amounts of TFA showed no significant associations with abdominal fatness, inflammatory markers, blood lipids, blood pressure and insulin homeostasis. Among middle-aged men with a generally low intake of TFA, neither I-TFA nor R-TFA was significantly related to obesity-associated risk markers of CHD. The decreased average intake of I-TFA in Denmark since 1995 is suggested to effectively prevent occurrence of the adverse metabolic changes and health consequences, which have formerly been observed in relation to, especially, I-TFA intake.


Sign in / Sign up

Export Citation Format

Share Document